These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29108996)

  • 21. Irisin levels in LMNA-associated partial lipodystrophies.
    Bensmaïne F; Benomar K; Espiard S; Vahe C; Le Mapihan K; Lion G; Lemdani M; Chazard E; Ernst O; Vigouroux C; Pigny P; Vantyghem MC
    Diabetes Metab; 2019 Jan; 45(1):67-75. PubMed ID: 30165155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy.
    Araújo-Vilar D; Lado-Abeal J; Palos-Paz F; Lattanzi G; Bandín MA; Bellido D; Domínguez-Gerpe L; Calvo C; Pérez O; Ramazanova A; Martínez-Sánchez N; Victoria B; Costa-Freitas AT
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):61-8. PubMed ID: 18031308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Familial partial lipodystrophy (Dunnigan syndrome) due to LMNA gene mutation: The first description of its clinical case in Russia].
    Sorkina EL; Kalashnikova MF; Melnichenko GA; Tyulpakov AN
    Ter Arkh; 2015; 87(3):83-87. PubMed ID: 26027246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular Metabolism and Bioenergetic Function in Human Fibroblasts and Preadipocytes of Type 2 Familial Partial Lipodystrophy.
    Algieri C; Bernardini C; Trombetti F; Schena E; Zannoni A; Forni M; Nesci S
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Dietary Intake, Leisure-Time Physical Activity, and Metabolic Profile in Women with Mutation in the LMNA Gene.
    Monteiro L; Foss-Freitas MC; Navarro A; Pereira F; Coeli F; Carneseca E; Júnior RM; Foss M
    J Am Coll Nutr; 2017; 36(4):248-252. PubMed ID: 28443701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiazolidinedione response in familial lipodystrophy patients with LMNA mutations: a case series.
    Luedtke A; Boschmann M; Colpe C; Engeli S; Adams F; Birkenfeld AL; Haufe S; Rahn G; Luft FC; Schmidt HH; Jordan J
    Horm Metab Res; 2012 Apr; 44(4):306-11. PubMed ID: 22274718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LMNA mutations, skeletal muscle lipid metabolism, and insulin resistance.
    Boschmann M; Engeli S; Moro C; Luedtke A; Adams F; Gorzelniak K; Rahn G; Mähler A; Dobberstein K; Krüger A; Schmidt S; Spuler S; Luft FC; Smith SR; Schmidt HH; Jordan J
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1634-43. PubMed ID: 20130076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mineralocorticoid Receptor Antagonism Prevents Type 2 Familial Partial Lipodystrophy Brown Adipocyte Dysfunction.
    Schena E; Mattioli E; Peres C; Zanotti L; Morselli P; Iozzo P; Guzzardi MA; Bernardini C; Forni M; Nesci S; Caprio M; Cecchetti C; Pagotto U; Gabusi E; Cattini L; Lisignoli G; Blalock W; Gambineri A; Lattanzi G
    Cells; 2023 Nov; 12(22):. PubMed ID: 37998321
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Jeru I; Vatier C; Vantyghem MC; Lascols O; Vigouroux C
    J Med Genet; 2017 Jun; 54(6):413-416. PubMed ID: 28408391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanisms of human lipodystrophies: from adipocyte lipid droplet to oxidative stress and lipotoxicity.
    Vigouroux C; Caron-Debarle M; Le Dour C; Magré J; Capeau J
    Int J Biochem Cell Biol; 2011 Jun; 43(6):862-76. PubMed ID: 21392585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-throughput Second-generation Sequencing Technology Assisted Diagnosis of Familial Partial Lipodystrophy (Type 2 Kobberling-Dunnigan Syndrome): A Case Report.
    Deng M; Chen W; Qi Y
    Comb Chem High Throughput Screen; 2024; 27(2):346-351. PubMed ID: 37231758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic Value of Anthropometric Measurements for Familial Partial Lipodystrophy, Dunnigan Variety.
    Vasandani C; Li X; Sekizkardes H; Adams-Huet B; Brown RJ; Garg A
    J Clin Endocrinol Metab; 2020 Jul; 105(7):2132-41. PubMed ID: 32193531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new laminopathy caused by an Arg133/Leu mutation in
    Wang Z; Dong Y; Yang J; He Y; Lin X; Wu F; Li H; Zheng F
    Adipocyte; 2019 Dec; 8(1):280-291. PubMed ID: 31293201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel LMNA mutations seen in patients with familial partial lipodystrophy subtype 2 (FPLD2; MIM 151660).
    Lanktree M; Cao H; Rabkin SW; Hanna A; Hegele RA
    Clin Genet; 2007 Feb; 71(2):183-6. PubMed ID: 17250669
    [No Abstract]   [Full Text] [Related]  

  • 35. Severe loss of adipose tissue in a Vietnamese lipodystrophy patient caused by
    Vu NP; Tran HT; Vu NB; Ma TTH; Nguyen TD; Nong HV; Nguyen HH
    J Pediatr Endocrinol Metab; 2022 Sep; 35(9):1206-1210. PubMed ID: 35822709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A recurrent familial partial lipodystrophy due to a monoallelic or biallelic LMNA founder variant highlights the multifaceted cardiac manifestations of metabolic laminopathies.
    Treiber G; Flaus Furmaniuk A; Guilleux A; Medjane S; Bonfanti O; Schneebeli S; Bernard C; Le-Moullec N; Bakiri F; Pholsena M; Rollot O; Vatier C; Jarlet E; Jéru I; Lascols O; Darcel F; Domun B; Venault A; Venault S; Jacquemont ML; Doray B; Maiza JC; Cogne M; Vigouroux C; Nobécourt E
    Eur J Endocrinol; 2021 Aug; 185(4):453-462. PubMed ID: 34292171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial partial lipodystrophy presenting as metabolic syndrome.
    Chan D; McIntyre AD; Hegele RA; Don-Wauchope AC
    J Clin Lipidol; 2016; 10(6):1488-1491. PubMed ID: 27919367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy.
    Vantyghem MC; Vincent-Desplanques D; Defrance-Faivre F; Capeau J; Fermon C; Valat AS; Lascols O; Hecart AC; Pigny P; Delemer B; Vigouroux C; Wemeau JL
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2223-9. PubMed ID: 18364375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case Report: An Atypical Form of Familial Partial Lipodystrophy Type 2 Due to Mutation in the Rod Domain of Lamin A/C.
    Cecchetti C; D'Apice MR; Morini E; Novelli G; Pizzi C; Pagotto U; Gambineri A
    Front Endocrinol (Lausanne); 2021; 12():675096. PubMed ID: 33953703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dunnigan-type familial partial lipodystrophy associated with the heterozygous R482W mutation in LMNA gene - case study of three women from one family.
    Nabrdalik K; Strózik A; Minkina-Pędras M; Jarosz-Chobot P; Młynarski W; Grzeszczak W; Gumprecht J
    Endokrynol Pol; 2013; 64(4):306-11. PubMed ID: 24002959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.